Shigella induced reactive arthritis

Annals of the Rheumatic Diseases

Volumn 64, Issue 4, 2005, Pages 517-518

  Gaston, J S Hill ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; BACTERIAL INFECTION; COMORBIDITY; HUMAN; IMMUNE SYSTEM; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SHIGELLA; SHIGELLA FLEXNERI; SHORT SURVEY;

ARTHRITIS, REACTIVE; DYSENTERY, BACILLARY; HUMANS; RISK FACTORS; SHIGELLA; TRAVEL;

EID: 16344365112     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.030395     Document Type: Short Survey

References (25)

1. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis 2005;64:594-8.
2. Kvien TK, Glennas A, Melby K, Granfors K, Andrup O, Karstensen B, et al. Reactive arthritis-incidence, triggering agents and clinical presentation. J Rheumatol 1994;21:115-22.
3. Lauhio A, Lahdevirta J, Janes R, Kontiainen S, Repo H. Reactive arthritis associated with Shigella sonnei infection. Arthritis Rheum 1988;31:1190-3.
4. Chen M, Delpech V, O'Sullivan B, Donovan B. Shigella sonnei: another cause af sexually acquired reactive arthritis. Int J STD AIDS 2002;13:135-6.
5. Simon DG, Kaslow RA, Rosenbaum J, Kaye RL, Calin A. Reiter's syndrome following epidemic shigellosis. J Rheumatol 1981;8:969-73.
6. Kaslow RA, Ryder RW, Calin A. Search for Reiter's syndrome after an outbreak of Shigella sonnei dysentery. J Rheumatol 1979;6:562-6.
7. Mazumder RN, Salam MA, Ali M, Bhattacharya MK. Reactive arthritis associated with Shigella dysenteriae type 1 infection. J Diarrhoeal Dis Res 1997;15:21-4.
8. Good AE. Shigellae and Reiter's syndrome. Ann Rheum Dis 1979;38(suppl 1):119-22.
9. LahesmaaRantala R, Toivanen A. Clinical spectrum of reactive arthritis. In: Toivanen A, Toivanen P, eds. Reactive arthritis. Boca Raton, FL: CRC Press, Inc, 1988.
10. van Bohemen CG, Grumet FC, Zonen HC. Identification of HLA-B27M1 and-M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology 1984;52:607-10.
11. Van Bohemen C, Nabbe A, Grumet F, Landheer J, Dinant H, Zonen H. Lack of correlation between HLA B27 like antigenic epitopes on Shigella flexneri and the occurrence of reactive arthritis. Opin Exp Immunol 1986;65:679-82.
12. Stieglitz H, Lipsky P. Association between reactive arthritis and antecedent infection with Shigella-flexneri carrying a 2-Md plasmid and encoding an HLA-B27 mimetic epitope. Arthritis Rheum 1993;36:1387-91.
13. Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001;2:797-801.
14. Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, et al. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun 2003;71:2775-86.
15. Grantors K, Jalkanen S, Toivanen P, Lindberg A. Bacteria! lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol 1992;19:500.
16. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999;285:732-6.
17. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004;5:975-9.
18. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
19. McGovern DP, van Heel DA, Ahmad T, Jewell DP. NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut 2001;49:752-4.
20. van der Paardt M, Crusius JB, de Koning MH, Murillo LS, van de Stadt RJ, Dijkmans BA, et al. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun 2003;4:77-8.
21. Ferreiros-Vidal I, Amarelo J, Barros F, Carracedo A, Gomez-Reino JJ, Gonzalez A. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease. J Rheumatol 2003;30:102-4.
22. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004;5:800-8.
23. Boisgerault F, Mounier J, Tieng V, Stolzenberg MC, Khalildaher I, Schmid M, et al. Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri. Infect Immun 1998;66:4484-90.
24. Urban RG, Chicz RM, Lane WS, Strominger JL, Rehm A, Kenter MJH, et al. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci USA 1994;91:1534-8.
25. Malik P, Klimovitsky P, Deng LW, Boyson JE, Strominger JL. Uniquely conformed peptide-containing beta 2-microglobulin-free heavy chains of HLA-B2705 on the cell surface. J Immunol 2002;169:4379-87.